Skip to main content
Fig. 1 | BMC Medical Imaging

Fig. 1

From: Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France

Fig. 1

Decision tree combined with the Markov model used for evaluating costs and health-related outcomes. BCR = patients with first biochemical recurrence of prostate cancer; CRPC: patient with castration-resistant prostate cancer; m0 and m1: patient with and without bone metastases, respectively

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us